OBJECTIVE: To determine if sequence variants in the glucokinase (GCK) gene contribute to the high risk of impaired glucose metabolism in Japanese-Americans and whether the gene sequence differs between Japanese-Americans and Caucasians. RESEARCH DESIGN AND METHODS: Forty-seven unrelated Japanese-Americans with one or more first-degree relatives with non-insulin-dependent diabetes mellitus (NIDDM) were selected, irrespective of glucose tolerance status. By World Health Organization criteria, 13 had normal glucose tolerance, 11 had impaired glucose tolerance, and 23 had NIDDM. Variations in the GCK gene were identified by single-strand conformation polymorphism analysis and sequenced using standard techniques. RESULTS: Six variants of the GCK gene were identified in a total of 21 subjects: 1) a G--> A substitution at nucleotide -30 in the beta-cell-specific promoter; 2) an A--> G substitution at nucleotide 244 in the 5'-untranslated region (5'-UTR) of exon 1a; 3) a C--> G substitution at nucleotide 403 in the 5'-UTR of exon 1a; 4) a G--> A variant 13 base pair (bp) 5' to the intron 3 exon 4 junction; 5) a silent substitution in the third base of codon 145 in exon 4; and 6) a C--> T substitution 8 bp 3' to the exon 9 intron 9 junction. None of these variations would be expected to affect the structure of the GCK enzyme. While none of these variants were significantly associated with IGT or NIDDM, a nonsignificant increase in the beta-cell promoter variant was observed in subjects with abnormal glucose tolerance. No uniform sequence differences in the GCK gene were identified between Japanese-American and Caucasian-American subjects. CONCLUSIONS: Mutations affecting the amino acid sequence of GCK do not account for the increased incidence of impaired glucose metabolism in Japanese-Americans, and the gene sequence does not uniformly differ from that in Caucasians.
OBJECTIVE: To determine if sequence variants in the glucokinase (GCK) gene contribute to the high risk of impaired glucose metabolism in Japanese-Americans and whether the gene sequence differs between Japanese-Americans and Caucasians. RESEARCH DESIGN AND METHODS: Forty-seven unrelated Japanese-Americans with one or more first-degree relatives with non-insulin-dependent diabetes mellitus (NIDDM) were selected, irrespective of glucose tolerance status. By World Health Organization criteria, 13 had normal glucose tolerance, 11 had impaired glucose tolerance, and 23 had NIDDM. Variations in the GCK gene were identified by single-strand conformation polymorphism analysis and sequenced using standard techniques. RESULTS: Six variants of the GCK gene were identified in a total of 21 subjects: 1) a G--> A substitution at nucleotide -30 in the beta-cell-specific promoter; 2) an A--> G substitution at nucleotide 244 in the 5'-untranslated region (5'-UTR) of exon 1a; 3) a C--> G substitution at nucleotide 403 in the 5'-UTR of exon 1a; 4) a G--> A variant 13 base pair (bp) 5' to the intron 3 exon 4 junction; 5) a silent substitution in the third base of codon 145 in exon 4; and 6) a C--> T substitution 8 bp 3' to the exon 9 intron 9 junction. None of these variations would be expected to affect the structure of the GCK enzyme. While none of these variants were significantly associated with IGT or NIDDM, a nonsignificant increase in the beta-cell promoter variant was observed in subjects with abnormal glucose tolerance. No uniform sequence differences in the GCK gene were identified between Japanese-American and Caucasian-American subjects. CONCLUSIONS: Mutations affecting the amino acid sequence of GCK do not account for the increased incidence of impaired glucose metabolism in Japanese-Americans, and the gene sequence does not uniformly differ from that in Caucasians.
Authors: Wilfred Y Fujimoto; Edward J Boyko; Tomoshige Hayashi; Steven E Kahn; Donna L Leonetti; Marguerite J McNeely; William P Shuman Journal: J Diabetes Investig Date: 2012-01-27 Impact factor: 4.232
Authors: Wei-Min Chen; Michael R Erdos; Anne U Jackson; Richa Saxena; Serena Sanna; Kristi D Silver; Nicholas J Timpson; Torben Hansen; Marco Orrù; Maria Grazia Piras; Lori L Bonnycastle; Cristen J Willer; Valeriya Lyssenko; Haiqing Shen; Johanna Kuusisto; Shah Ebrahim; Natascia Sestu; William L Duren; Maria Cristina Spada; Heather M Stringham; Laura J Scott; Nazario Olla; Amy J Swift; Samer Najjar; Braxton D Mitchell; Debbie A Lawlor; George Davey Smith; Yoav Ben-Shlomo; Gitte Andersen; Knut Borch-Johnsen; Torben Jørgensen; Jouko Saramies; Timo T Valle; Thomas A Buchanan; Alan R Shuldiner; Edward Lakatta; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Oluf Pedersen; Antonio Cao; Leif Groop; Karen L Mohlke; Markku Laakso; David Schlessinger; Francis S Collins; David Altshuler; Gonçalo R Abecasis; Michael Boehnke; Angelo Scuteri; Richard M Watanabe Journal: J Clin Invest Date: 2008-07 Impact factor: 14.808